A Systematic Review of the MDMA Model to Address Social Impairment in Autism.

CONCLUSION: MDMA and/or MDMA-like molecules appear to be an effective pharmacological treatment for the social impairments of autism, at least in animal models. Notably, clinical trials based on MDMA use are now in progress. Nevertheless, larger and more extended clinical studies are warranted to prove the assumption that MDMA and MDMA-like molecules have a role in the management of the social impairments of autism.
PMID: 33388021 [PubMed - as supplied by publisher]

Source: Current Neuropharmacology - January 1, 2021 Category: Drugs & Pharmacology Authors: Chaliha D, Mamo JC, Albrecht M, Lam V, Takechi R, Vaccarezza M Tags: Curr Neuropharmacol Source Type: research